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Abstract
Background: Cervical cancer is the first female cancer in Lao PDR, a low-income country with no national screening
and prevention programs for this human papillomavirus (HPV) associated pathology. HIV-infected women have a
higher risk of persistent oncogenic HPV infection.
The purpose of this study was to determine the knowledge, awareness and attitudes about cervical cancer among
Lao women attending or not an HIV treatment center, in order to understand if this attendance had offered an
opportunity for information and prevention.
Methods: A cross-sectional case–control survey was conducted in three provinces of Lao PDR, Vientiane, Luang
Prabang and Savannakhet. Cases were 320 women aged 25 to 65, living with HIV and followed in an HIV treatment
center. Controls were 320 women matched for age and place of residence, not attending an HIV treatment center.
Results: Cases had a greater number of sexual partners and used condoms more often than controls. Only 36.6%
of women had consulted a gynecologist (47.5% among cases and 25.6% among controls, p < 0.001) and 3.9% had
benefited from at least one Pap smear screening (5.6% cases and 2.2% controls, p = 0.02). The average knowledge
score was 3.5 on a 0 to 13 scale, significantly higher in cases than in controls (p < 0.0001). Despite having a lower
education level and economic status, the women living with HIV had a better knowledge about cervical cancer and
were more aware than the controls of the risk of developing such a cancer (35.9% vs. 8.4%, p = 0.0001). The main
source of information was healthcare professionals. The main reasons for not undergoing Pap smear were the
absence of symptoms and the default of medical injunction for cases, the lack of information and ignorance of
screening usefulness for controls.
Conclusion: In Lao PDR, routine consultation in HIV treatment centers is not enough harnessed to inform women
of their high risk of developing cervical cancer, and to perform screening testing and treatment of precancerous
lesions. Implementing this cost-effective strategy could be the first step toward a national prevention program for
cervical cancer.
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Background
Cervical cancer is the second most common cancer in
women worldwide, with over 90% of cases occurring in
developing countries [1]. A persistent infection with a high
risk oncogenic Human papillomavirus (HR-HPV) is in-
volved in almost all cases [2]. HPV infection is very com-
mon in young women with early sexual activity, with a
peak before 25 years, usually without clinical consequence
[3]. In nearly 10% of cases, this infection persists and is
associated after 5 to 10 years with lesions that may regress,
remain stable or progress to a higher grade and invasive
cancer. Evolution of cervical intraepithelial neoplasia (CIN)
to invasive cancer is slow, about 10 to 20 years for an im-
munocompetent woman [4]. This slow progression allows
an effective secondary prevention based on screening and
treatment of precancerous lesions, using cervical cytological
testing according Papanicolaou (Pap smear or Pap test),
visual inspection of the cervix with 3–5% acetic acid (VIA),
or more recently HPV DNA testing.
Immunosuppression, especially due to human immuno-
deficiency virus (HIV) infection, is a predisposing factor
for persistent infection with HR-HPV [5] and the develop-
ment of squamous intraepithelial lesions (SIL) [6]. High
HIV viral loads and low CD4 counts are associated with a
higher risk of HR-HPV infection and cervical abnormal-
ities [7]. The risk of recurrence or progression of cervical
lesions is 4–5 times higher in women living with HIV [8].
Infection with one of the 15 HR-HPV genotypes is signifi-
cantly more common in HIV-infected women [9], while
the distribution of low-risk oncogenic HPV is not affected
by HIV status [10]. This reflects a higher propensity of
HR-HPV in determining persistent infections [11].
Before the era of antiretroviral therapy, the life expect-
ancy of HIV-infected women was too short for a systematic
cervical cancer screening program to demonstrate effective-
ness [12]. Today, despite highly active antiretroviral therapy
(HAART) guided by CD4 count, the probability of develop-
ing invasive cervical cancer remains high and stable in this
population at risk [13,14]. Thus, the follow-up of women
on antiretroviral therapy offers an opportunity for cervical
cancer screening in resource-poor countries [15,16]. A pro-
spective study with a follow-up over 10 years on a cohort of
1760 HIV-infected and 472 non HIV-infected women
showed that HIV-positive women who benefitted from
regular screening had no greater risk of developing invasive
cancer than HIV-negative women [17].
Laos has a female population of 1.79 million aged 15
and older. Cervical cancer is the most common cancer in
women with a 15.8 per 100,000 estimated crude incidence.
It is also the second leading cause of cancer death in
women, but the primary cause between 15 and 44 years
[18]. As in most low-income countries, there are no na-
tional screening and prevention programs for cervical can-
cer in Lao PDR and awareness of women is still very low.
The prevalence of HIV infection in Lao PDR is relatively
low compared to neighboring countries, around 0.2%
among adults aged 15–49 in the general population. In
2011, the number of women living with HIV was estimated
at 5,263 and 50.9% of eligible women were receiving
HAART under the National HIV/AIDS Program supported
by the Global Fund [19]. Patients are followed in seven
treatment centers, two in the capital of Vientiane, the other
five in the provinces of Luang Prabang, Savannakhet, Luang
Namtha, Bokeo and Pakse. There is currently no routine
screening program for cervical cancer in women living with
HIV in Laos. As the primary prevention of cervical cancer
by vaccination is not effective in women already infected
by HPV, the only recourse is the secondary prevention
through early detection and treatment of SIL [13]. Attend-
ing HIV treatment centers is an opportunity to educate
women about the risks and the value of cytological screen-
ing. The aim of this study was to determine the knowledge
and awareness of Lao women about cervical cancer and to
evaluate the impact of medical care for HIV-infected
women on their risk awareness and prevention behaviors.
Methods
Study type
A cross-sectional case–control survey was conducted by
interviews in three provinces selected for the presence of
HIV treatment centers: Vientiane capital (1,320 patients
followed, including 581 women), Luang Prabang in the
north (138 patients including 62 women) and Savannakhet
in the south (1171 patients, including 844 women).
Study population
The sample size was calculated to be 640 (320 cases and
320 controls) on the assumption that in the group
followed in the HIV treatment centers (cases), the relative
percentage of women aware of cervical cancer was 10%
higher than in the control group, with a precision of 10%,
an alpha risk of 5%, and a 90% power.
The cases were HIV-positive women, aged 25 to 65,
living in the province and regularly monitored in the
HIV treatment centers. Controls were women matched
on age and dwelling place, not attending HIV treatment
centers. Women unable to respond to questions or not
willing to participate in the study were excluded.
From the 560 HIV-infected women who met the inclu-
sion criteria in the three provinces (30 in Luang Prabang,
190 in Vientiane and 340 in Savannakhet), 320 were ran-
domly selected. For each case, a control with the same age
(± 1 year), living in the same district was randomly drawn
from the census of residents.
Data collection
A standardized questionnaire was used to collect infor-
mation upon knowledge, awareness and attitudes of
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women about the risk of cervical cancer and its prevention.
The questionnaire consisted of four sections: (i) socio-
demographic data, (ii) risk behaviors for sexually transmit-
ted infections (STIs) and immune status for HIV-infected
women, (iii) knowledge on cervical cancer and its preven-
tion, (iv) attitudes towards prevention and screening (see
Additional file 1). All the questions were tested before the
survey. The level of knowledge was assessed on 13 ques-
tions, possible answers being “yes/no/do not know.” Am-
biguous responses were clarified using complementary
open questions. For each respondent, the overall knowledge
scores were calculated as the sum of correct answers, values
ranging from 0 up to 13 [20]. Open-ended questions were
also asked in the fourth section to specify the reasons for
the non-use of neither gynecological consultation nor
screening.
The cases were recruited during their visit to the HIV
treatment center. Seropositivity and immune status were
checked on their medical records. The questionnaire was
administered anonymously and confidentially by a female
physician (CS), student of IFMT especially trained in in-
vestigation. The interviews took place in a private room
for an average time of 15 to 20 minutes. The cases not
regularly monitored by the center were visited at home.
Controls were recruited in the same district of residence
than matched cases and were interviewed at home using
the same standardized questionnaire. After the interview,
the women were given counselling on cervical cancer
screening.
Data analysis
Data entry was performed using SPSS Version 19 soft-
ware, and analyses of variables performed with STATA
version 11. We used the Chi 2 test or Fisher exact to com-
pare qualitative variables, Student’s t test and ANOVA for
quantitative variables with normal distribution, Wilcoxon
and Kruskal-Wallis tests for quantitative variables with
non-normal distribution. Factors associated to a score of
knowledge about cervical cancer better than 3 (dependant
variable) were assessed by logistic regression. All inde-
pendent variables with a p-value under 0.25% in univariate
analyses were considered and included in the initial model
in a unconditional way. The final model was obtained using
backward elimination i.e. the progressive elimination of
non-significant factors by decreasing order of significance.
Results of univariate and multivariate analyses (final model)
were merged and presented in the same table. For all ana-
lyses, a p-value under 0.05 was considered as significant.
Ethical clearance
Women enrolled in this study received a clear descrip-
tion of the study objectives and the working methods.
They were informed that the investigation concerned
sexuality and addressed some information upon their
privacy, but that all data would remain anonymous and
confidential. They were free to accept or decline the
interview and signed an informed consent form in case
of acceptance. The study received approval from the
National Ethics Committee of the Ministry of Health of
Lao PDR and was carried out with the authorization of
the HIV treatment centers in the three provinces.
Results
The theoretical sample size of 640 women was achieved
in the three sites: 434 in Savannakhet (67.8%), 146 in
Vientiane (22.8%) and 60 in Luang Prabang (9.4%). Only
three women refused the interview. At each site, 50% of re-
cruited women were cases and 50% were matched controls.
Socio-demographics
The mean age of these 640 women was 36.2 ± 8 years
(range 25–63), 80% were married and almost all were
Buddhist (96%). Occupations were mainly farmer (32.7%)
and shopkeeper (27.2%). The significant differences be-
tween cases and controls were the number of children, the
level of education and the average monthly income, all
higher in the control group (Table 1).
Risk factors
The average age at first intercourse was 18.6 ± 2.7 years,
almost identical in both groups. Women living with HIV
had more sexual partners, used condoms more often and
consumed more tobacco than controls. However, the use
of contraceptive methods other than condoms, including
the combined pill, was more common among controls.
Overall 234 women (36.6%) had consulted a gynecologist
and 25 (3.9%) had had one Pap smear test. These two
practices were significantly more frequent among women
living with HIV (Table 2). The number of gynecological
consultations was related to education level (p = 0.01) and
amount of income (p = 0.001), but these two factors had
no significant influence on the use of the Pap smear.
Clinical and immunological status of women living
with HIV
Among the 320 HIV infected women, 181 (56.6%) had a
history of one or more opportunistic infections and 289
(90.3%) were on antiretroviral therapy, regularly followed
in the majority of cases. The follow-up in HIV treatment
centers was planned once a month in Vientiane and Luang
Prabang and once every two months in Savannakhet. The
CD4 cell count was less than 200/mm3 in 162 (50.6%)
patients.
Knowledge about cervical cancer
For all the women surveyed, the average knowledge score
noted from 0 up to 13 was 3.5 ± 2.1 (range: 0–11). Unre-
lated to age, the highest scores were recorded among
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Table 1 Demographic characteristics, risk factors and behaviours of women followed in the HIV treatment centres
(cases) and matched controls
Demographic characteristics Total Cases Controls p
N = 640 (%) N = 320 (%) N = 320 (%)
Mean age 36.2 ± 8 36.3 ± 8.1 36.1 ± 7.9 0.70
Marital status 0.10
Single 30 (4.7) 10 (3.1) 20 (6.3)
Bride/concubine 513 (80.2) 256 (80) 257 (80.3)
Divorced/widow 97 (15.2) 54 (16.9) 43 (13.4)
Average number of children 2.3 ± 1.5 2.0 ± 1.5 2.6 ± 1.4 <0.0001
Religion 0.40
Buddhist 614 (95.9) 305 (95.3) 309 (96.5)
Animistic 26 (4.1) 15 (4.6) 11 (3.4)
Education level 0.002
Illiterate 48 (7.5) 26 (8.1) 22 (6.9)
Primary 337 (52.7) 188 (58.8) 149 (46.6)
Secondary 255 (39.8) 106 (33.1) 149 (46.6)
Occupation 0.20
Housewife 110 (11.2) 53 (16.6) 57 (17.8)
Civil servant 50 (7.8) 20 (6.3) 30 (9.4)
Shopkeeper 174 (27.2) 82 (25.6) 92 (28.8)
Farmer 209 (32.7) 113 (35.3) 96 (30)
Factory woman 88 (13.8) 45 (14.1) 43 (13.4)
Hairdresser 5 (0.8) 3 (0.9) 2 (0.6)
Sex worker 4 (0.6) 4 (1.3) 0
Average income/month (US dollars) 85.3 ± 69.2 79.2 ± 46.1 91.4 ± 85.8 0.01
Province 1.00
Luang Prabang 60 (9.4) 30 (9.4) 30 (9.4)
Savannakhet 434 (67.8) 217 (67.8) 217 (67.8)
Vientiane 146 (22.8) 73 (22.8) 73 (22.8)
Risk factors and behaviours
Average age at first intercourse 18.6 ± 2.7 18.6 ± 2.9 18.7 ± 2.4 0.80
Average number of sexual partners 2.5 ± 6.3 3.6 ± 8.7 1.5 ± 1.3 <0.0001
Current use of condom <0.001
- Never 338 (52.8) 81 (25.3) 257 (80.3)
- Sometimes 61 (20.2) 32 (13.4) 29 (46.0)
- Often 48 (15.9) 33 (13.8) 15 (23.8)
- Always 193 (63.9) 174 (72.8) 19 (30.2)
Current method of contraception*
- Oral or injectable contraception 104 (16.3) 25 (7.8) 79 (24.7) <0.001
- Coitus interruptus 28 (4.4) 5 (1.6) 23 (7.2) 0.001
- Intra-uterine device 11 (2.5) 3 (1.1) 8 (4.6) 0.10
- Tubal ligation 4 (0.9) 1 (0.3) 3 (1.7) 0.30
Smoking 82 (12.8) 57 (17.8) 25 (7.8) <0.001
Have consulted a gynaecologist 234 (36.6) 152 (47.5) 82 (25.6) <0.001
Have had ≥ 1 Pap smear screening 25 (3.9) 18 (5.6) 7 (2.2) 0.02
*including condom use.
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Table 2 Knowledge and attitudes of cases (women followed in the HIV treatment centres) and matched controls
Knowledge about sexually transmitted infections
(STIs) and cervical cancer (CC)
Total Cases Controls p
N = 640 N = 320 N = 320
(%) (%) (%)
Able to name: at least 1 STI 417 (65.2) 290 (90.6) 127 (39.7) 0.0001
1 STI 207 (32.3) 151 (47.1) 58 (18.1) 0.0001
2 STI 122 (19.1) 79 (24.7) 43 (13.4) 0.0001
3 STI 68 (10.6) 47 (14.7) 21 (6.6) 0.001
4 STI 20 (3.1) 13 (4.1) 5 (1.6) 0.05
Have heard about:
- CC 344 (53.8) 177 (55.3) 167 (52.2) 0.40
- Human papillomavirus (HPV) 37 (5.8) 14 (4.4) 23 (7.2) 0.10
- HPV vaccination 65 (10.2) 41 (12.8) 24 (7.5) 0.02
Knowledge scores (0 to 13) ≤ 3 351 (54.8) 146 (45.6) 205 (64.1) 0.0001
> 3 289 (45.2) 174 (54.4) 115 (35.9)
Knowing someone with CC 118 (18.4) 41 (12.8) 77 (24.1) 0.0002
Knowing that:
- CC is a serious condition 318 (49.7) 186 (58.1) 132 (41.3) 0.0001
- CC is caused by HPV infection 20 (3.1) 10 (3.1) 10 (3.1) 1.00
- Multiple sexual partners are a risk factor of CC 224 (35) 179 (55.9) 45 (14.1) 0.01
Able to name at least:
- One risk factor for CC 49 (7.7) 29 (9.1) 20 (6.3) 0.10
- One screening method of CC 17 (2.7) 11 (3.4) 6 (1.9) 0.20
- One prevention method of CC 105 (16.4) 51 (15.9) 54 (16.9) 0.70
Mentioned prevention methods of CC:
- Drugs 41 (6.4) 14 (4.4) 27 (8.4) 0.05
- Vaccination 156 (24.4) 46 (14.4) 110 (34.4) 0.0001
- Annual gynaecological exam 294 (45.9) 184 (57.5) 110 (34.4) 0.0001
- Vaccination and annual gynaecological exam 149 (23.1) 83 (25.9) 66 (20.3) 0.08
Sources of information on CC:
- Health professionals 197 (30.8) 127 (39.7) 70 (21.9) 0.0001
- Medias 82 (12.8) 28 (8.8) 54 (16.9) 0.002
- Family and relatives 65 (10.6) 22 (6.9) 43 (13.4) 0.006
Sources of information on HPV vaccination
- Health professionals 45 (7.0) 29 (9.1) 16 (5.0) 0.04
- Medias 16 (2.5) 9 (2.8) 7 (2.2) 0.60
- Family and relatives 4 (0.6) 3 (0.9) 1 (0.3) 0.60
Attitudes with respect to the risk of CC
Believing:
- That CC is a common disease in Laos 323 (50.5) 183 (57.2) 140 (43.8) 0.0007
- To be herself at risk of developing CC 142 (22.2) 115 (35.9) 27 (8.4) 0.0001
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single women, of secondary education level, civil servant,
with a monthly income greater than 85 USD and living
in Vientiane province. Scores were significantly higher
among women living with HIV than in controls (p <
0.0001), except among unmarried and women living in the
province of Luang Prabang.
In multivariate analysis after logistical regression,
five variables were independently found associated
with a score of knowledge upon cervical cancer higher
than 3: occupation, province, education level, matri-
monial status and HIV status (Table 3). Civil servants
were more than 9 times more aware about cervical
cancer than housewives (reference value). Women at-
tending care in Vientiane were almost 4 times more
aware than those in Luang Prabang. Those who had
reached at least the secondary school education level
were 3.2 times more aware than illiterates ones.
Women divorced or widowed were 3.1 times more
aware than single ones. Finally, people living with HIV
were found 2.8 times more aware than controls.
A slight majority of respondents (53.8%) had heard of
cervical cancer and 18.4% knew someone with the dis-
ease. Most felt that it is a serious condition but only 40
(6.3%) were aware of the role of HPV. Women living
with HIV had a significantly higher level of knowledge
about STIs in general, the severity of cervical cancer, the
risk related to the number of sexual partners and pre-
vention methods (Table 2).
Table 2 Knowledge and attitudes of cases (women followed in the HIV treatment centres) and matched controls
(Continued)
Regarding as risk factors for CC:
- HIV infection 413 (64.5) 236 (73.8) 177 (55.3) 0.0001
- Unprotected intercourse 560 (87.5) 293 (91.6) 267 (83.4) 0.001
- Multiple sexual partners 574 (89.7) 297 (92.8) 277 (86.6) 0.01
- Smoking 265 (41.5) 125 (39.1) 140 (43.9) 0.20
Wishing:
- National recommendations for HPV vaccination 582 (90.9) 288 (90.0) 294 (91.9) 0.40
- To be vaccinated if an affordable HPV vaccine is offered 568 (88.8) 288 (90.0) 280 (87.5) 0.30
Table 3 Logistical regression: factors associated with a score of knowledge upon cervical cancer higher than 3
Variables Univariate analysis Multivariate analysis
cOR CI95% p aOR CI95% p
Occupation
Civil servant (ref: housewife) 8.18 [3.50; 19.09] <0.001 9.23 [3.52; 24.0168] <0.001
Shopkeeper (ref: housewife) 1.36 [0.84; 2.20] 0.2
Farmer (ref: housewife) 0.99 [0.61; 1.58] 0.9
Factory woman (ref: housewife) 0.93 [0.53; 1.66] 0.8
Province
Vientiane (ref: Savannakhet) 1.82 [1.25; 2.66] 0.002
Vientiane (ref: Luang Prabang) 1.98 [1.07; 3.64] 0.03 3.77 [1.78; 7.99] 0.001
Education level
Primary (ref: illiterate) 1.43 [0.74; 2.77] 0.3
At least secondary (ref: illiterate) 3.47 [1.77; 6.78] <0.001 3.20 [1.53; 6.70] 0.002
Marital status
Bride/concubine (ref: single) 3.06 [1.37; 6.81] 0.006
Divorced/widow (ref: single) 2.59 [1.08; 6.22] 0.03 3.09 [1.53; 6.70] 0.002
HIV status
Case (ref: control) 2.12 [1.53; 2.94] <0.001 2.78 [1.95; 3.96] <0.001
Monthly income (US $)
At least 85$ (ref: lower than 85$) 1.96 [1.42; 2.70] <0.001
Ref, Reference; cOR, Crude Odd Ratio; CI95%, 95% Confidence Interval; aOR, Adjusted Odd Ratio.
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Health professionals were the main source of informa-
tion, especially for women living with HIV (p = 0.0001),
whereas controls rather knew the disease by the media
(p = 0.002) or their family (p = 0.006).
Attitudes towards the risk of cervical cancer
Half of the women interviewed believed that cervical can-
cer is a common disease in Laos, but only 22% felt them-
selves at risk, this proportion being higher among women
living with HIV (p = 0.0001). Similarly, the risk factors as-
sociated with HIV infection, unprotected sex and multiple
partners were better perceived by cases than by controls.
In both groups, a large majority of women wished that a
preventive vaccine for cervical cancer be recommended by
the government and planned to benefit themselves from it
if its cost was moderate (Table 2).
Among women living with HIV, the main reason for
non-completion of Pap smear screening was the absence
of symptoms (p < 0.0001) and the lack of injunction from
the doctor (p = 0.04). Other reasons were the lack of infor-
mation on screening and its usefulness, more often alleged
by the controls (Table 4).
Discussion
Early detection of pre-cancerous lesions is universally
recognized as the most effective method of preventing
cervical cancer. However low-income countries, where
this cancer has the highest incidence, still face many
challenges to establish national prevention programs
[21]. Thus in Laos the screening coverage for women
aged 18 to 69 years was estimated at 2.2%, 5.2% in urban
areas and 1.4% in rural areas [18]. The level of women’s
knowledge about risk factors and prevention of cervical
cancer is a major determinant to undergo screening tests
[22]. This survey is the first one conducted among Lao
women aged 25 to 65 on knowledge, awareness and atti-
tude about cervical cancer. It has been conducted in
three different regions of the country and involved a rep-
resentative sample of the female population living with
HIV and a matched control group.
The first result of this study is that the general level of
knowledge of the women interviewed is very poor, most
being unable to mention any STI, never having heard of
HPV and knowing no way to prevent cervical cancer.
Knowledge mean scores are even lower than those found
in Chiang Mai, Thailand, in a survey upon 402 sex
workers. This difference could be explained by the fact
that Thai STI services also offer a Pap screening for ex-
posed women [20]. The best knowledge scores were ob-
served in women with a secondary education level and
earning more than 85 US dollars per month. Similar
results are found in different studies conducted in low-
income countries such as Cameroon [22], Nigeria [23],
Tanzania [21], and Ethiopia [24]. In addition, the civil
servant status which gives access to social insurance
in Laos and the residence in Vientiane capital, where
access to care is easier than in the provinces, are
factors independently associated with a higher level of
knowledge.
Almost half of women have heard of cervical cancer and
consider it as a serious and common disease in Laos. But
being aware does not necessarily correspond to a correct
understanding of the disease [25]. Although a large major-
ity cites unprotected sex and multiple sex partners as main
risk factors, only 6% know the causal link between HR-
HPV infection and cervical cancer. This rate was 14%
among sex workers in Chiang Mai [20] and reached 64%
in a multicenter survey in the United States [26], but in
both cases, the questionnaire offered a multiple-choice
question for this item.
The other interesting aspect highlighted by the survey
is that HIV infected women have a significantly higher
level of knowledge than their controls, although their
average level of education is lower. The same observa-
tion was made in a study conducted in the United States
on 1588 women, including 71% HIV positive, showing
that women living with HIV had better understanding
of the prevention of cervical cancer than HIV-negative
women [26]. In our survey, this difference is observed
mainly on issues related to sexually transmitted nature
of the infection, HIV and HPV sharing common routes
of transmission. There is also evidence that women
living with HIV are more likely to use condoms and to
consult a gynecologist than controls.
Table 4 Reasons for not undergoing a Pap smear
screening among cases (women followed in the HIV
treatment centres) and matched controls
Reasons Total Cases Controls p
N = 615 N = 302 N = 313
(%) (%) (%)
No symptoms 203 (33.0) 139 (46.0) 64 (20.4) 0.0001
Never heard of screening 160 (26.0) 64 (21.2) 96 (30.7) 0.003
Believing it is not necessary 92 (14.9) 33 (10.9) 59 (18.8) 0.003
Not enough available 51 (8.3) 17 (5.6) 34 (10.9) 0.01
Not prescribed by the doctor 33 (5.4) 22 (7.3) 11 (3.5) 0.04
Fear to be too expensive 22 (3.6) 13 (4.3) 9 (2.9) 0.30
No risk factor 19 (3.1) 9 (1.5) 10 (3.2) 0.80
Fear of painful sampling 17 (2.8) 0 (0) 17 (5.4) 0.0001
Screening centre too far 7 (1.1) 4 (1.3) 3 (0.9) 1.00
Fear of an abnormal result 5 (0.8) 0 (0) 5 (1.6) 0.06
Shame or embarrassment 4 (0.7) 1 (0.3) 3 (0.9) 0.60
Absence of sexual activity 2 (0.3) 0 (0) 2 (0.6) 0.50
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However, knowledge about risk factors for cervical
cancer, screening methods and means of prevention are
similarly poor in both groups. Few women consider
themselves at risk of developing cervical cancer. Al-
though this awareness is four times higher among HIV-
infected women (35.9%) than among controls (8.4%),
it does not lead to a greater practice of smear screening.
Indeed, only 5.6% of HIV infected women had under-
gone a Pap test. A similar proportion (5%) was found in
a study conducted among 300 women attending an
HIV treatment center in Lagos, Nigeria, in the absence
of national program for cervical cancer screening [27].
In addition, half of HIV-infected women in our study
had a CD4 count below 200/mm3. This immune defi-
ciency is associated with an increased risk of cervical
dysplasia, but has also been identified as a risk factor
for non-adherence to Pap smear program in a US
survey [28].
It is noteworthy that the absence of symptoms was the
reason given by one third of women and 46% of women
infected with HIV for not performing testing. The same
reason, advanced by 67% of sex workers in a study in
Thailand, reflects a total ignorance of the natural history
of cervical cancer and the principle of Pap screening,
hence the need to strengthen the education of these
highly exposed women [20].
The finding that nearly 90% of women in both groups
hope national recommendations for vaccination against
HPV and would agree to receive it should be interpreted
with caution. This wish ignores that vaccination is only
for girls who have not started their sexual life, while
commercial vaccines do not protect against all types of
HPV circulating in Southeast Asia [29].
Health personnel represent the main source of infor-
mation for women living with HIV, before media and
family or friends entourage. Regular attendance of HIV
treatment centers has an obvious impact on the aware-
ness of the risk of cervical cancer, but it still has no
effect on screening behavior. Several reasons could be
advanced. First, physicians responsible for monitoring
and treatment of HIV patients do not have sufficient
training to counsel their patients on the prevention of
cervical cancer. A survey conducted in Karachi, Pakistan,
amongst interns and nursing staff in tertiary care hospi-
tals showed that only 40% knew the Pap smear as a
screening tool for cervical cancer [30]. Second, the HIV
post-test counseling and the therapeutic monitoring are
not used to discuss the screening of cervical cancer. As
in many low-income countries, this screening is not
part of the routine management of HIV-infected women
and health practitioners in HIV treatment centers do
not receive proper training [27]. Third, the screening
capacities in the Lao health system do not yet allow
responding to a systematic demand for all women at
risk. In addition, the cost of Pap smear, around 10 U.S.
dollars, is a deterrent for a majority of women who do
not have social insurance.
Our study has some limitations like all surveys by
questionnaire covering information about private life.
Response biases through default of sincerity are hard to
avoid completely. Regarding the cases, it was not pos-
sible to determine the anteriority and regularity of con-
sultations in HIV treatment centers. In addition, the
HIV-negative status of controls could not be confirmed,
this position being assumed on the non-attendance of
HIV treatment centers.
The main result of this survey is the highlight of a
wide ignorance on cervical cancer and its prevention
amongst Lao women. It urges to implement information
campaigns on a national scale specifically targeting
women aged 25 to 65. This health education must take
into account the ability to understand and the cultural
characteristics of women. It is necessary to improve the
communication skills to effectively convey prevention
messages to women less educated [31]. This is the case
of women belonging to various ethnic minorities in
Southeast Asia, who also accumulate a large number of
risk factors for cervical cancer as young age of mar-
riage, early sexual activity and a high number of preg-
nancies [32]. The sessions should ensure not to
stigmatize less educated women by exposing their ig-
norance [26]. Trainers should also avoid causing can-
cer anxiety among women as observed after the launch
of an awareness and screening program In Khon Kaen,
Thailand [33].
However, even well-conducted, an health education
campaign will remain ineffective if the means of second-
ary prevention are lacking. Counseling and screening for
cervical cancer should be included in the National HIV/
AIDS programs [34] and implemented in all HIV treat-
ment centers [27]. Knowing the high prevalence of SIL
in HIV-infected women, the screening cannot be tar-
geted on the basis of clinical considerations [35] but has
to become routine from the age of 25 years. Where cyto-
logical screening is not available, it would be relevant to
integrate low cost rapid testing at such as VIA, allowing
immediate treatment with cryotherapy within a single
“see-and-treat” visit. Then, when the screening service is
implemented, it can be extended to all women, regard-
less of their HIV status [36].
Given the screening tools for cervical cancer currently
available (cytology, VIA, HPV DNA), it is up to each
country to determine, according to its capacities, the
most cost-effective strategy for women living with HIV
[37]. In Lao PDR, further studies will determine the
screening policy best adapted to the scarcity of re-
sources in view of an increasing incidence of cervical
cancer.
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Conclusions
Dying from cervical cancer is not a fatality in the karma
of Lao women whose vulnerability is primarily due to
their ignorance of the HR-HPV infection and its conse-
quences. Despite they are significantly more aware,
women living with HIV who bear additional risk of cer-
vical cancer, still have a very poor understanding of the
means to prevent it. They should be better informed by
the health personnel and be offered a more systematic
access to testing.
The implementation of routine screening for cervical
cancer in HIV treatment centers would be a significant
first step toward a national prevention program aiming
at the elimination of a deadly but preventable cancer.
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